- Home
- Companies
- canada quebec
- cancer risk
Show results for
Refine by
Industries served
- Medical / Health Care
- Chemical & Pharmaceuticals
- Monitoring and Testing
- Forestry & Wood
- Metal
- Pulp & Paper
- Agriculture
- Health and Safety
- Air and Climate
- Food and Beverage
- Construction & Construction Materials
- Aerospace & Air Transport
- Oil, Gas & Refineries
- Water and Wastewater
- Soil and Groundwater
- Government
- Manufacturing, Other
- Energy
Cancer Risk Suppliers Serving Quebec
36 companies found
based inBoston, MASSACHUSETTS (USA)
SOPHiA GENETICS is the creator of a global data-sharing network – we work with customers from over 790 institutions in over 70 countries. Our network advances data-driven medicine to improve health outcomes and economics worldwide. We offer a ...
Confidently assess genetic variants predisposing to cancer. Hereditary causes account for ∼10% of cancer cases, and an estimated 20% of cancer patients have a family history of ...
based inValladolid, SPAIN
Founded in 2010, AMADIX is a leading molecular diagnostics company, focused on liquid biopsy, developing innovative diagnostic tests for early cancer detection in blood. Our mission is to extend people’s lives by developing disruptive technologies ...
It can also be used as a tool for a high-risk screening population in combination with Low Dose Computed Tomography (LDCT). DiagnoLung identifies and measures proteins which are differentially expressed in blood samples of ...
based inNewark, DELAWARE (USA)
ANP’s on-site technical support team is awesome! We ran into some testing problems with the NIDS multiplexed hand held assays and reader during initial testing. Upon our request, ANP immediately sent their tech support team to our test site and ...
based inGuro-gu, SOUTH KOREA
We provide diagnostic solutions throughout the cancer treatment cycle from early cancer diagnosis to prognostic and companion diagnostics as well as postoperative monitoring. Diagnose cancer as early as possible, when the disease is easiest to ...
Multigene prognostic test predicts the probability of metastasis or recurrence, which helps patients make treatment decision. It improves quality of life for cancer patients as preventing them from unnecessary ...
based inNotting Hill, AUSTRALIA
INOVIQ Ltd (ASX:IIQ) (INOVIQ) is developing and commercialising an innovative portfolio of diagnostic and exosome-based solutions for the earlier detection, diagnosis, prognosis and monitoring of cancer and other diseases to improve patient outcomes ...
INOVIQ has three autoantibody tests in development for early detection of ovarian, breast and lung cancers. BARD1 autoantibody tests measure autoantibodies to variant BARD1 proteins in the blood and use a proprietary cancer-specific algorithm to ...
based inAustin, TEXAS (USA)
Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more ...
Empower is a genetic test for those who want to know more about their risk of developing cancer, why it might be common in their family, or want to inform treatment options following a cancer ...
based inRedwood City, CALIFORNIA (USA)
Guardant Health is a leading precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics. We’re developing blood tests for early detection in high-risk populations and ...
based inChatham, UNITED KINGDOM
MD Diagnostics was launched in 2008, with over 40 years of respiratory medical device knowledge to benefit from. We have now become a recognised market-leading force in breath monitoring. Supplying and servicing thousands of healthcare staff ...
Dental professionals have a unique opportunity to address smoking with patients in a manner that will make a difference. Brief advice from a dentist or member of the dental team has been shown to increase a patient’s motivation to quit and can ...
based inAnkara, TURKEY
Neosys is a prominent medical products manufacturer, specializing in the field of arthroscopy. Since our establishment in 2013, we have gained a reputation as a manufacturer with the highest quality standards and integrity. Commitment to Provide ...
Glucosamine is one of the most common supplements that people get when they have joint pain. In support, it is usually taken in the form of glucosamine sulfate, in combination with ...
based inShirley, NEW YORK (USA)
CD Bioparticles is an established drug delivery company which provides customized solutions for developing and producing new, biocompatible drug delivery systems. We specialize in a range of formulation and drug delivery technologies, from ...
based inBerlin, GERMANY
BIOTRONIK is a leading global medical device company with products and services that save and improve the lives of patients suffering from cardiovascular and endovascular diseases. Patient well-being is our top priority and has been for more than 50 ...
based inCaesarea, ISRAEL
IceCure Medical is an Israeli medical device company founded in 2006 to advance treatment of cancerous tumors. IceCure’s core technology is based on cryoablation, using freezing temperature (liquid nitrogen) to destroy tumors safely, quickly, and ...
We are dedicated to providing reliable clinical support for the ProSense™ System, so that physicians and other stakeholders can adopt our technology with confidence as the gold standard in tumor therapy. ICE3 is the largest controlled ...
based inBeloit, WISCONSIN (USA)
We are innovators who revolutionized the reliable production of Mo-99. We are dedicated to preserving the environment using non-uranium production methods. We are pioneers working with industry leaders to develop and commercialize new diagnostics ...
As a radioisotope central to diagnostic imaging tests, technetium-99m (Tc-99m) is in high demand worldwide. NorthStar innovation makes a reliable domestic supply of Tc-99m possible for the 40,0001 patients in the U.S. every single day who rely on it ...
based inSan Diego, CALIFORNIA (USA)
Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging PCR-based epigenetics, our pioneering testing approach uses ...
Bladder cancer is the 5th most common cancer in the western world, and 70%-80% of the patients are diagnosed with non-muscle invasive disease. There are estimated 400,000 to 800,000 active bladder cancer patients in the United States, as well as 1 ...
based inEmeryville, CALIFORNIA (USA)
SCS Global Services is a global leader in independent certification of environmental, sustainability, food quality and safety claims. Food & Ag Training - online, Auditing and Certification services for: SQF, BRCGS, FSSC22000, HACCP, FSMA PCQI, ...
based inSyracuse, NEW YORK (USA)
Mesothelioma is an aggressive cancer that affects the lining of the lungs, heart, or abdomen. Caused by the inhalation of asbestos fibers, mesothelioma is often diagnosed in older individuals who worked with asbestos products. Prognosis for ...
Lung cancer is one of the most common cancers, and researchers estimate about 3 – 4% of all cases can be attributed to asbestos ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
N-Nitroso-N-methylurea (NMU;MNU;NMH) is a potent carcinogen, mutagen and teratogenand. N-Nitroso-N-methylurea is a direct-acting alkylating agent that interacts with DNA. N-Nitroso-N-methylurea targets multiple animal organs to cause various cancer ...
based inHuntsville, ALABAMA (USA)
Kailos Genetics provides consumers access to affordable physician-ordered genetic tests. It is our mission to help people take control of their health and make more informed decisions. The Kailos test is an easily accessible genetic test catered to ...
based inRichmond, BRITISH COLUMBIA (CANADA)
BioMark is an oncology-focused company with advanced near-to- market liquid biopsy diagnostic technologies. Our technology improves patient comfort, outcomes and early cancer detection. Biomark owns various intellectual properties, developed for the ...
BioMark has invested in and developed a new high powered liquid biopsy metabolic panel assay. The new metabolic assay is instrumental for early stage diagnosis of lung ...
based inRockville, MARYLAND (USA)
20/20 GeneSystems (“20/20”) is focused on on reducing cancer deaths worldwide through its years of experience in the development and use of cancer biomarker test development. By leveraging this expertise and combining it with advanced machine ...
Comprehensive health screening, something common in many countries outside of the U.S. has been something that is rarely accessible for most Americans. By placing a high priority on early detection, most cancers can be survivable when detected early ...